Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral TXA & GSH in melasma
NCT07448415Phase 3Not yet recruiting
- Sponsor
- Assiut University
- Start
- Feb 2026
- Primary completion
- Feb 2027
- Modality
- Peptides, Recombinant Proteins and Enzymes, Small Molecules
01
Overview
A Phase 3 trial of tranexamic acid, glutathione in melasma, sponsored by Assiut University. Planned start Feb 2026; status: not yet recruiting.
02
Drugs
tranexamic acidglutathione
03
Conditions
melasma
Beyond the preview
Go deeper on NCT07448415.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07448415.